Judge To Weigh Attempt To Revive Bayer FCA Claims
A New Jersey federal judge has agreed to review recent decisions supporting arguments that Bayer Pharmaceutical Corp. should repay the government for allegedly off-label marketed drugs in a whistleblower False Claims...To view the full article, register now.
Already a subscriber? Click here to view full article